BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26797634)

  • 21. On the Potential Significance of the Intrinsically Disordered Regions in the Clostridiodes difficile Toxins A and B.
    El Hadidy N; Uversky VN; Sun X
    Curr Protein Pept Sci; 2022 Jul; 23(3):192-209. PubMed ID: 35585826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The enterotoxicity of Clostridium difficile toxins.
    Sun X; Savidge T; Feng H
    Toxins (Basel); 2010 Jul; 2(7):1848-80. PubMed ID: 22069662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Clostridium difficile toxin A and B on human T lymphocyte migration.
    Wu D; Joyee AG; Nandagopal S; Lopez M; Ma X; Berry J; Lin F
    Toxins (Basel); 2013 May; 5(5):926-38. PubMed ID: 23645153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile-derived membrane vesicles induce the expression of pro-inflammatory cytokine genes and cytotoxicity in colonic epithelial cells in vitro.
    Nicholas A; Jeon H; Selasi GN; Na SH; Kwon HI; Kim YJ; Choi CW; Kim SI; Lee JC
    Microb Pathog; 2017 Jun; 107():6-11. PubMed ID: 28284851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of Clostridium difficile TcdA and TcdB toxins with transition state analogues.
    Paparella AS; Aboulache BL; Harijan RK; Potts KS; Tyler PC; Schramm VL
    Nat Commun; 2021 Nov; 12(1):6285. PubMed ID: 34725358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enteric glial cells counteract Clostridium difficile Toxin B through a NADPH oxidase/ROS/JNK/caspase-3 axis, without involving mitochondrial pathways.
    Macchioni L; Davidescu M; Fettucciari K; Petricciuolo M; Gatticchi L; Gioè D; Villanacci V; Bellini M; Marconi P; Roberti R; Bassotti G; Corazzi L
    Sci Rep; 2017 Mar; 7():45569. PubMed ID: 28349972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-resolved cellular effects induced by TcdA from Clostridium difficile.
    Jochim N; Gerhard R; Just I; Pich A
    Rapid Commun Mass Spectrom; 2014 May; 28(10):1089-100. PubMed ID: 24711272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of an epithelial cell receptor responsible for Clostridium difficile TcdB-induced cytotoxicity.
    LaFrance ME; Farrow MA; Chandrasekaran R; Sheng J; Rubin DH; Lacy DB
    Proc Natl Acad Sci U S A; 2015 Jun; 112(22):7073-8. PubMed ID: 26038560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TcdB or not TcdB: a tale of two Clostridium difficile toxins.
    Carter GP; Awad MM; Kelly ML; Rood JI; Lyras D
    Future Microbiol; 2011 Feb; 6(2):121-3. PubMed ID: 21366410
    [No Abstract]   [Full Text] [Related]  

  • 30. Clostridium difficile toxin B-induced necrosis is mediated by the host epithelial cell NADPH oxidase complex.
    Farrow MA; Chumbler NM; Lapierre LA; Franklin JL; Rutherford SA; Goldenring JR; Lacy DB
    Proc Natl Acad Sci U S A; 2013 Nov; 110(46):18674-9. PubMed ID: 24167244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
    Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
    Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TcdB of
    Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of recombinant Clostridium difficile toxin A and B in Bacillus megaterium.
    Yang G; Zhou B; Wang J; He X; Sun X; Nie W; Tzipori S; Feng H
    BMC Microbiol; 2008 Nov; 8():192. PubMed ID: 18990232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular methods to study transcriptional regulation of Clostridium difficile toxin genes.
    Antunes A; Dupuy B
    Methods Mol Biol; 2010; 646():93-115. PubMed ID: 20597005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
    Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
    J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enteropathogenic Escherichia coli effector NleH inhibits apoptosis induced by Clostridium difficile toxin B.
    Robinson KS; Mousnier A; Hemrajani C; Fairweather N; Berger CN; Frankel G
    Microbiology (Reading); 2010 Jun; 156(Pt 6):1815-1823. PubMed ID: 20223805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells.
    Song J; Shen X; Huang Z; Liu Y; Cui L; Cui X; Liu CY
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22652. PubMed ID: 33251692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.
    Di Bella S; Ascenzi P; Siarakas S; Petrosillo N; di Masi A
    Toxins (Basel); 2016 May; 8(5):. PubMed ID: 27153087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium difficile toxin B inhibits the secretory response of human mast cell line-1 (HMC-1) cells stimulated with high free-Ca²⁺ and GTPγS.
    Balletta A; Lorenz D; Rummel A; Gerhard R; Bigalke H; Wegner F
    Toxicology; 2015 Feb; 328():48-56. PubMed ID: 25497110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxin B Variants from
    López-Ureña D; Orozco-Aguilar J; Chaves-Madrigal Y; Ramírez-Mata A; Villalobos-Jimenez A; Ost S; Quesada-Gómez C; Rodríguez C; Papatheodorou P; Chaves-Olarte E
    Toxins (Basel); 2019 Jun; 11(6):. PubMed ID: 31212980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.